Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Diffuse Esophageal Spasm: Randomised Double-blind Sham Trial
2010-018298-39Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in Diffuse Esophageal Spasm (DES) and esophageal spasm (2 arms), sponsored by UZ Leuven. Primary endpoints: Symptom severity change and Esophageal manometry changes. Started Jan 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Diffuse Esophageal Spasm (DES)esophageal spasm
Beyond the preview
Go deeper on 2010-018298-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018298-39.